7th Apr 2009 11:09
ARK THERAPEUTICS GROUP PLC
7 April 2009
Annual Information Update
Ark Therapeutics Group plc (the "Company") is pleased to provide an annual information update in accordance with the requirements of Prospectus Rule 5.2. This update refers to information that has been published or made available by the Company to the public in the 12 months up to and including 31 March 2009.
The following UK regulatory announcements have been made via the Regulatory News Service provided by the London Stock Exchange:
|
Date |
Headline |
|
1 April 2008 |
Annual Information Update |
|
17 April 2008 |
Product Update |
|
22 April 2008 |
Regulatory Update |
|
24 April 2008 |
AGM Results |
|
16 May 2008 |
Interim Management Statement |
|
19 May 2008 |
Research Update |
|
22 May 2008 |
Holdings in Company |
|
30 May 2008 |
Research Update |
|
30 May 2008 |
Voting Rights and Capital |
|
2 June 2008 |
Regulatory Approval |
|
3 June 2008 |
Blocklisting Interim Review |
|
3 June 2008 |
Blocklisting Interim Review |
|
6 June 2008 |
Blocklisting Application |
|
18 June 2008 |
Research Update |
|
24 June 2008 |
Holdings in Company |
|
8 July 2008 |
Ark opens new manufacturing facility in Finland |
|
16 July 2008 |
Research Update |
|
30 July 2008 |
Research Update |
|
31 July 2008 |
Holding(s) in Company |
|
1 August 2008 |
Voting Rights and Capital |
|
26 August 2008 |
Holding(s) in Company |
|
27 August 2008 |
Research Update |
|
27 August 2008 |
Interim Results |
|
17 September 2008 |
Holding(s) in Company |
|
30 September 2008 |
Voting Rights and Capital |
|
2 October 2008 |
Ark secures reimbursement for Neuropad |
|
20 October 2008 |
Product Launch |
|
13 November 2008 |
Interim Management Statement |
|
24 November 2008 |
Director/PDMR Holding |
|
1 December 2008 |
Regulatory Application |
|
5 December 2008 |
Blocklisting Six Monthly Return |
|
9 December 2008 |
Regulatory Approval |
|
16 December 2008 |
Notification of Major Interest in Shares |
|
31 December 2008 |
Total Voting Rights |
|
6 January 2009 |
Research Update |
|
8 January 2009 |
Trinam® Phase III trial to commence |
|
9 January 2009 |
Holding(s) in Company |
|
14 January 2009 |
Re: Agreement |
|
21 January 2009 |
Notice of Results |
|
2 February 2009 |
Director/PDMR Shareholding |
|
5 February 2009 |
Dealing by Employee Benefit Trust |
|
16 February 2009 |
Research Update |
|
16 February 2009 |
Holding(s) in Company |
|
17 February 2009 |
Holding(s) in Company |
|
26 February 2009 |
Patent Filing |
|
2 March 2009 |
Voting Rights and Capital |
|
11 March 2009 |
Final Results |
|
13 March 2009 |
Holding(s) in Company |
|
17 March 2009 |
Holding(s) in Company |
Copies of all regulatory announcements for Ark Therapeutics Group plc can be found on the Press Release Archive page on the Company's website www.arktherapeutics.com
The Ark Therapeutics Group plc Annual Report and Accounts 2008 and the Interim Report 2008 were filed on 25 March 2009 and 3 September 2008 respectively at the UKLA Document Viewing Facility, Financial Services Authority, 25 The Colonnade, Canary Wharf, London E14 5HS. These documents are also available on the Company's website www.arktherapeutics.com or on application to the Company Secretary.
The Company has also made the following filings at Companies House:
|
Date of Filing |
Document filed |
|
1 April 2008 |
Return of Allotment of Shares |
|
24 April 2008 |
Resolutions passed at AGM |
|
24 April 2008 |
New Articles of Association |
|
24 April 2008 |
Form 288b Terminating appointment as director |
|
24 April 2008 |
Form 288a Appointment of director |
|
20 May 2008 |
Return of Allotment of Shares |
|
18 August 2008 |
Return of Allotment of Shares |
|
22 September 2008 |
Return of Allotment of Shares |
|
1 October 2008 |
New Articles of Association |
|
14 November 2008 |
Annual Return |
|
17 December 2008 |
Return of Allotment of Shares |
|
26 February 2009 |
Return of Allotment of Shares |
|
31 March 2009 |
Annual Report and Accounts 2008 |
Copies of these documents may be obtained from Companies House, Crown Way Maindy, Cardiff CF14 3UZ or through Companies House Direct at www.direct.companieshouse.gov.uk.
Further information is available regarding the Company and its activities on its website www.arktherapeutics.com.
The information referred to in this update was up to date at the time the information was published, but some information may now be out of date.
Enquiries:
|
Ark Therapeutics Group plc Martyn Williams, Company Secretary |
020 7388 7722 |
Related Shares:
PVG.L